How can biohacking professionals evaluate peptide research?
What scientific evidence, human trial data, safety information, and regulatory sources should a biohacking professional review before discussing an experimental peptide publicly?
What scientific evidence, human trial data, safety information, and regulatory sources should a biohacking professional review before discussing an experimental peptide publicly?
What warning signs can help me distinguish verifiable research product information from unsupported claims about purity, safety, effectiveness, or regulatory approval?
How can I tell whether a peptide treatment is an approved medicine, a compounded preparation, or an experimental product, and why does the distinction matter?
How much extra time should I allow if my product needs an import permit or regulatory review?